drugset / Trial / NCT00978146
Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to examine the response rate of desmoid tumors to hydroxyurea. The investigators hypothesize that hydroxyurea will be a safe, non-toxic alternative to aggressive surgery or chemotherapy for this difficult to treat tumor.
Timeline
- Start
- 2009-10
- Primary completion
- 2015-01
- Completion
- 2015-01
Outcome
Outcome not reported
Stopped (Enrollment): “Study was administratively withdrawn by the IRB; no subjects were enrolled”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxyurea | Other / unclassified | 20 mg/kg | Oral |